KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Shares Issued (2016 - 2026)

Bio-Rad Laboratories has reported Shares Issued over the past 18 years, most recently at $3.4 million for Q1 2026.

  • Quarterly Shares Issued fell 20.93% to $3.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.9 million through Mar 2026, down 17.22% year-over-year, with the annual reading at $15.8 million for FY2025, 17.71% down from the prior year.
  • Shares Issued was $3.4 million for Q1 2026 at Bio-Rad Laboratories, down from $3.9 million in the prior quarter.
  • Over five years, Shares Issued peaked at $7.6 million in Q3 2022 and troughed at $3.4 million in Q3 2025.
  • The 5-year median for Shares Issued is $4.3 million (2023), against an average of $4.6 million.
  • Year-over-year, Shares Issued skyrocketed 148.84% in 2022 and then crashed 33.33% in 2025.
  • A 5-year view of Shares Issued shows it stood at $4.4 million in 2022, then fell by 1.14% to $4.3 million in 2023, then dropped by 9.97% to $3.9 million in 2024, then changed by 0.0% to $3.9 million in 2025, then decreased by 12.82% to $3.4 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Shares Issued are $3.4 million (Q1 2026), $3.9 million (Q4 2025), and $3.4 million (Q3 2025).